Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities
- 9 November 2021
- journal article
- review article
- Published by Elsevier in Seminars in Immunology
- Vol. 55, 101522
Abstract
No abstract availableKeywords
This publication has 112 references indexed in Scilit:
- Type III interferons (IFNs): Emerging Master Regulators of Immunity2015
- Type I interferons in infectious diseaseNature Reviews Immunology, 2015
- A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virusNature Genetics, 2013
- Sensing of RNA Viruses: a Review of Innate Immune Receptors Involved in Recognizing RNA Virus InvasionJournal of Virology, 2012
- The SARS Coronavirus 3a Protein Causes Endoplasmic Reticulum Stress and Induces Ligand-Independent Downregulation of the Type 1 Interferon ReceptorPLOS ONE, 2009
- Severe Acute Respiratory Syndrome Coronavirus M Protein Inhibits Type I Interferon Production by Impeding the Formation of TRAF3·TANK·TBK1/IKKϵ ComplexJournal of Biological Chemistry, 2009
- Innate immunity to virus infectionImmunological Reviews, 2008
- Severe Acute Respiratory Syndrome Coronavirus Evades Antiviral Signaling: Role of nsp1 and Rational Design of an Attenuated StrainJournal of Virology, 2007
- IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complexNature Immunology, 2002
- IL-28, IL-29 and their class II cytokine receptor IL-28RNature Immunology, 2002